The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

29 Jan 2019 12:45

RNS Number : 4297O
Pennant International Group PLC
29 January 2019
 

For immediate release

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

Pennant International Group plc

("Pennant", the "Company" or the "Group") 

 

Results of the Placing

 

Further to the accelerated bookbuilding process announced earlier today, Pennant International Group plc is pleased to announce the results of an oversubscribed placing with institutional investors of 2,281,110 Placing Shares, comprising 1,647,160 Fundraising Shares and 633,950 Available Option Shares. The Placing was conducted at a price of 110 pence per Placing Share. The Placing Price represents a discount of 3.93 per cent. to the closing price on 28 January 2019, the last trading day prior to this announcement.

 

The gross proceeds of the Fundraising amounting to £1.8 million (before expenses) together with the proceeds of the exercise of the 690,000 share options amounting to approximately £331,525 will predominantly be used to fund the potential Acquisition and to facilitate further new product development, as detailed in the Company's earlier announcement today. A further announcement will be made about the Acquisition in due course.

 

Application for admission to trading on AIM for 2,337,160 New Ordinary Shares (comprising 1,647,160 Fundraising Shares and 690,000 Option Shares) being issued pursuant to the Fundraising and the exercise of share options has been made and Admission is expected to take place on 1 February 2019. The New Ordinary Shares will rank pari passu with the Existing Ordinary Shares in issue. The New Ordinary Shares will represent approximately 6.48 per cent. of the Enlarged Issued Share Capital on Admission (assuming no other issuance of ordinary shares prior to Admission).

 

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the New Ordinary Shares, its issued share capital will comprise 36,040,693 Ordinary Shares of 5 pence each. All of these Ordinary Shares have equal voting rights and none of the Ordinary Shares are held in Treasury. The total number of voting rights in the Company will therefore be 36,040,693 on Admission.

 

Pennant's Chief Executive Officer, Phil Walker, said: "We are delighted by the support we have received for this fundraising which will enable us to accelerate our Group strategy of increasing both commercial and recurring revenues through the planned Acquisition and further investment in innovative new products."

 

Terms used in this Announcement shall have the meanings given to such terms in the definitions section of the appendix to the announcement made by the Company at 7.00 a.m. this morning.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Enquiries:

 

 

Pennant International Group plc

 

Simon Moore (Chairman)

+44 (0) 1452 714914

Philip Walker (Chief Executive Officer)

+44 (0) 1452 714914

 

 

WH Ireland Limited (Nominated Adviser and Broker)

 

Mike Coe / Chris Savidge (Corporate Finance)

+44 (0) 117 945 3470

Jasper Berry / Adam Pollock (Corporate Broking)

+44 (0) 207 220 1666

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0) 207 933 8780

+44 (0) 776 880 7631

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROILKLFLKFFZBBX
Date   Source Headline
7th Nov 20198:15 amRNSHoldings in Company
31st Oct 201910:48 amRNSNew £3.4m Contract Award and Qatar Update
24th Sep 20197:00 amRNS2019 Interim Results
9th Sep 20197:00 amRNSLaunch of Aviation Skills Charter
15th Aug 201910:07 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirector/PDMR Shareholding
9th Aug 20197:00 amRNSPre-Close Trading Update
31st Jul 20196:11 pmRNSHolding(s) in Company
19th Jul 20197:00 amRNSAcquisition of Track Access
18th Jun 20197:00 amRNSHolding(s) in Company
14th Jun 20197:31 amRNSAppointment of Non-Executive Director
2nd May 20191:30 pmRNSDirector Dealings
2nd May 20197:00 amRNSMajor Programme Update
1st May 20193:30 pmRNSResult of AGM
9th Apr 20197:00 amRNSIssue of Equity and Director Dealings
19th Mar 20195:02 pmRNSHolding(s) in Company
12th Mar 20195:21 pmRNSPublication of 2018 Annual Report
12th Mar 20197:00 amRNS2018 Final Results
8th Feb 20194:17 pmRNSDirector Dealing
7th Feb 20197:35 amRNSAcquisition Completed
4th Feb 201910:22 amRNSHolding(s) in Company
4th Feb 201910:19 amRNSHolding(s) in Company
29th Jan 201912:45 pmRNSResult of Placing
29th Jan 20197:00 amRNSProposed Placing
21st Jan 20197:00 amRNSTrading Update
18th Dec 20184:48 pmRNSHolding(s) in Company
12th Nov 20183:36 pmRNSHolding in Company
8th Nov 201810:31 amRNSMajor New Contract Award & Contracts Update
16th Oct 201810:15 amRNSHoldings in Company
15th Oct 20185:32 pmRNSHoldings in Company
12th Oct 20183:31 pmRNSHoldings in Company
10th Oct 20187:00 amRNSExercise of Share Options & Total Voting Rights
2nd Oct 20187:00 amRNSMajor Contract Award: £10.2m Middle East Order
24th Sep 20187:00 amRNS2018 Interim Results
21st Aug 20187:00 amRNSNew Customer Contract Award & Contract Extension
14th Aug 20189:00 amRNSHoldings in Company
10th Aug 20182:00 pmRNSHolding in Company
9th Aug 20187:00 amRNSProvisional "Down Selection" on Major Programme
27th Jul 20187:00 amRNSPre-Close Trading Update & Notice of Results
18th Jul 20189:46 amRNSHolding in Company
25th Apr 20184:59 pmRNSResult of AGM
24th Apr 201810:26 amRNSHolding in Company
23rd Mar 20185:16 pmRNSDirectors' Dealings
20th Mar 20187:00 amRNSMajor UK Contract Update & £10m SOI received
12th Mar 20187:00 amRNSDirectorate Changes: Board Appointments
12th Mar 20187:00 amRNS2017 Final Results
12th Feb 20187:00 amRNSTrading Update, IFRS15 Impact & Notice of Results
30th Jan 20187:00 amRNSPennant International Group plc: 60th Anniversary
10th Jan 20182:00 pmRNSHolding(s) in Company
4th Dec 20177:00 amRNSTeaming Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.